BioPharmSignal logoBioPharmSignal

Biotech News

Enlivex Treasury Portfolio Update: RAIN Holdings Valued at Approximately $1.16 Billion; Rain Foundation Appoints Industry Leaders to Advisory Board

Enlivex Therapeutics (ENLV)Enlivex TherapeuticsCompany update

As of May 27, 2026, Enlivex held 79,568,550,005 RAIN tokens with a total value of approximately $1.16 billion.

Separately, the Rain Foundation recently announced the appointment of five industry leaders to its advisory board, supporting the next phase of...

Related news

ENLVEnlivex Therapeutics2026-06-22 13:45 EST

Enlivex Treasury Portfolio Update: RAIN Holdings Valued at Approximately $1.14 Billion

ENLVEnlivex Therapeutics2026-07-20 13:00 EST

Enlivex Treasury Portfolio Update: NAV Per Ordinary Share $66.16; Total Treasury Holdings Valued at Approximately $1.1 Billion

TPSTTempest Therapeutics2026-06-04 20:37 EST

Tempest Therapeutics Appoints Drake Richey and John Yee, MD, MPH to Board of Directors

CADLCandel Therapeutics2026-06-25 12:05 EST

Candel Therapeutics Appoints Mark Sims as Chief Commercial Officer

TPSTTempest Therapeutics2026-05-29 12:00 EST

Tempest Therapeutics Announces Warrant Exercise for Approximately $2 Million in Gross Proceeds

View all latest news

Enlivex Therapeutics

Enlivex Therapeutics is an immunotherapy company focused on macrophage reprogramming and inflammation-related disease. Its story is centered on harnessing innate immunity to address hard-to-treat conditions.

Recent company news

ENLVEnlivex Therapeutics2026-07-30 13:00 EST

Enlivex Treasury Portfolio Update: RAIN Trading Volume Reaches $860MM, 622% Month-Over-Month Growth in July vs June

ENLVEnlivex Therapeutics2026-07-29 13:00 EST

Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones

ENLVEnlivex Therapeutics2026-07-29 13:00 EST

Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones

ENLVEnlivex Therapeutics2026-07-28 13:00 EST

Enlivex Announces $400,000,000 Private Placement

ENLVEnlivex Therapeutics2026-07-28 13:00 EST

Enlivex Announces $400,000,000 Private Placement

Stock data

Close
1.98 USD
Market cap
204.87M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States